Arkema (AKE) AI Stock Analysis

• Market Cap: €4.07B
• Dividend Yield: 6.72%
• Average Volume (3M): 192.90K
• Price to Earnings (P/E): 18.7
• Beta (1Y): 1.32
• Revenue Growth: 0.19%
• EPS Growth: -37.62%
• Country: FR
• Employees: 21,150
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 1.56
• Shares Outstanding: 76,060,830
• 10 Day Avg. Volume: 248,635
• 30 Day Avg. Volume: 192,895
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €73.25
• Price Target Upside: 36.66% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 9

• Rating: 70 Outperform
• Price Target: €68.00 ▲(26.87% Upside)

Arkema's overall stock score reflects a stable financial position with challenges in revenue and cash flow, balanced by attractive dividend yield and moderate technical indicators. The lack of earnings call and corporate events data limits further insights.

Positive Factors

Negative Factors

Arkema Business Overview & Revenue Model

Company Description

Arkema (AKE) is a global specialty chemicals and advanced materials company headquartered in France. It operates through three main segments: High Performance Materials, Industrial Specialties, and Coating Solutions. Arkema's core products include advanced polymers, adhesive solutions, and specialty chemicals that serve a diverse range of industries such as automotive, construction, electronics, and consumer goods. The company is committed to innovation and sustainability, focusing on developing solutions that address environmental challenges.

How the Company Makes Money

Arkema generates revenue primarily through the sale of its specialty chemicals and materials across various market sectors. The company has a diverse revenue model that includes direct sales to manufacturers and end-users, as well as partnerships with key players in the industries it serves. Significant revenue streams come from its High Performance Materials segment, which produces advanced materials used in high-growth applications like electric vehicles and renewable energy. Additionally, Arkema benefits from strategic collaborations and acquisitions that enhance its product offerings and market reach, contributing positively to its earnings.

Arkema Financial Statement Overview

Summary

Arkema's financial performance shows challenges in revenue growth and profitability margins, with a stable balance sheet but declining cash flow metrics. The company maintains operational efficiency, but needs to address declining revenue and cash flow to ensure long-term financial health.

Income Statement

Arkema's income statement shows a declining trend in revenue and profitability margins over the TTM period. The gross profit margin and net profit margin have decreased compared to previous years, indicating pressure on profitability. Revenue growth has been negative, reflecting challenges in maintaining sales momentum. However, the company maintains a positive EBIT and EBITDA margin, suggesting operational efficiency despite the downturn.

Balance Sheet

The balance sheet reflects a stable financial position with a moderate debt-to-equity ratio, indicating manageable leverage. The return on equity has decreased, suggesting reduced profitability for shareholders. The equity ratio remains healthy, showing a strong capital structure. Overall, the balance sheet suggests financial stability but highlights the need for improved profitability.

Cash Flow

Cash flow analysis reveals a decline in free cash flow growth, which could impact future investments and debt servicing. The operating cash flow to net income ratio is moderate, indicating adequate cash generation relative to earnings. However, the free cash flow to net income ratio has decreased, pointing to potential liquidity challenges. The company needs to focus on improving cash flow generation to support its financial commitments.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	9.44B	9.54B	9.51B	11.55B	9.52B	7.88B
Gross Profit	1.80B	1.94B	1.96B	2.58B	2.14B	1.55B
EBITDA	1.10B	1.31B	1.33B	1.82B	2.27B	1.19B
Net Income	226.00M	354.00M	402.00M	965.00M	1.31B	332.00M
Balance Sheet
Total Assets	13.92B	15.21B	14.52B	13.51B	12.30B	10.71B
Cash, Cash Equivalents and Short-Term Investments	1.31B	2.01B	2.04B	1.59B	2.29B	1.63B
Total Debt	3.79B	4.55B	4.28B	3.26B	2.76B	2.80B
Total Liabilities	6.47B	7.45B	7.06B	6.17B	5.95B	5.48B
Stockholders Equity	7.23B	7.53B	7.20B	7.30B	6.30B	5.19B
Cash Flow
Free Cash Flow	211.00M	353.00M	622.00M	766.00M	152.00M	510.00M
Operating Cash Flow	1.00B	1.12B	1.26B	1.50B	915.00M	1.11B
Investing Cash Flow	-900.00M	-940.00M	-1.35B	-2.34B	473.00M	-458.00M
Financing Cash Flow	-953.00M	-207.00M	516.00M	168.00M	-652.00M	-535.00M

Arkema Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 53.60
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:AKE, the sentiment is Negative. The current price of 53.6 is below the 20-day moving average (MA) of 56.93, below the 50-day MA of 59.75, and below the 200-day MA of 65.31, indicating a bearish trend. The MACD of -1.70 indicates Positive momentum. The RSI at 26.27 is Positive, neither overbought nor oversold. The STOCH value of 12.73 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:AKE.

Arkema Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CBE	74 Outperform	€1.59B	14.83	16.32%	1.39%	10.55%	13.50%
AKE	70 Outperform	€4.07B	18.75	3.56%	6.72%	0.19%	-37.62%
VK	66 Neutral	€3.93B	10.59	17.38%	8.94%	-15.12%	-10.10%
AI	66 Neutral	€101.55B	29.76	12.31%	1.88%	1.46%	12.62%
NK	55 Neutral	€1.90B	-11.35	-2.90%	6.48%	-7.71%	-451.19%
ERA	50 Neutral	€1.59B	-16.35	0.97%	2.72%	-6.91%	-222.35%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%